APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Testosterone

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Transdermal Testosterone Industry Growth and Trends Forecast to 2032

Report ID 174042660120 December 2025105 pages

Choose your research edition.

Industry ResearchTransdermal Testosterone Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Testosterone Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Transdermal Testosterone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Testosterone Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Testosterone Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Transdermal Testosterone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Transdermal Testosterone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Transdermal Testosterone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transdermal Testosterone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Transdermal Testosterone include Teva, AbbVie, Upsher-Smith Laboratories, Perrigo, Lupin, Endo Pharmaceuticals, Dr. Reddy's Laboratories, Cipla Inc. and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Transdermal Testosterone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Transdermal Testosterone market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Transdermal Testosterone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Transdermal Testosterone.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Transdermal Testosterone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Transdermal Testosterone Market by Company

Teva

AbbVie

Upsher-Smith Laboratories

Perrigo

Lupin

Endo Pharmaceuticals

Dr. Reddy's Laboratories

Cipla Inc.

Allergan

Acerus Pharmaceuticals

Transdermal Testosterone Segment by Type

Gel

Patch

Transdermal Testosterone Segment by Application

Late-Onset Hypogonadism

Hypogonadotropic Hypogonadism

Primary Hypogonadism

Transdermal Testosterone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Testosterone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Testosterone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Testosterone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Transdermal Testosterone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Transdermal Testosterone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Gel Table 2. Major Company of Patch Table 3. Global Transdermal Testosterone Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Transdermal Testosterone Sales by Type (2021-2026) & (W Units) Table 5. Global Transdermal Testosterone Sales Market Share in Volume by Type (2021-2026) Table 6. Global Transdermal Testosterone Sales by Type (2021-2026) & (US$ Million) Table 7. Global Transdermal Testosterone Sales Market Share in Value by Type (2021-2026) Table 8. Global Transdermal Testosterone Price by Type (2021-2026) & (US$/Unit) Table 9. Global Transdermal Testosterone Sales by Type (2027-2032) & (W Units) Table 10. Global Transdermal Testosterone Sales Market Share in Volume by Type (2027-2032) Table 11. Global Transdermal Testosterone Sales by Type (2027-2032) & (US$ Million) Table 12. Global Transdermal Testosterone Sales Market Share in Value by Type (2027-2032) Table 13. Global Transdermal Testosterone Price by Type (2027-2032) & (US$/Unit) Table 14. North America Transdermal Testosterone Sales by Type (2021-2026) & (W Units) Table 15. North America Transdermal Testosterone Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Transdermal Testosterone Sales by Type (2021-2026) & (W Units) Table 17. Europe Transdermal Testosterone Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Transdermal Testosterone Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Transdermal Testosterone Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Transdermal Testosterone Sales by Type (2021-2026) & (W Units) Table 21. Latin America Transdermal Testosterone Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Transdermal Testosterone Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Transdermal Testosterone Sales by Type (2021-2026) & (US$ Million) Table 24. Transdermal Testosterone Industry Trends Table 25. Transdermal Testosterone Industry Drivers Table 26. Transdermal Testosterone Industry Opportunities and Challenges Table 27. Transdermal Testosterone Industry Restraints Table 28. Global Transdermal Testosterone Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Transdermal Testosterone Revenue Market Share by Company (2021-2026) Table 30. Global Transdermal Testosterone Sales by Company (2021-2026) & (W Units) Table 31. Global Transdermal Testosterone Sales Share by Company (2021-2026) Table 32. Global Transdermal Testosterone Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Transdermal Testosterone Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Transdermal Testosterone Major Company Production Sites and Headquarters Table 35. Global Transdermal Testosterone Company, Product Type & Application Table 36. Global Transdermal Testosterone Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Transdermal Testosterone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Transdermal Testosterone Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Transdermal Testosterone Sales by Region (2021-2026) & (W Units) Table 41. Global Transdermal Testosterone Sales Market Share in Volume by Region (2021-2026) Table 42. Global Transdermal Testosterone Sales by Region (2021-2026) & (US$ Million) Table 43. Global Transdermal Testosterone Sales Market Share in Value by Region (2021-2026) Table 44. Global Transdermal Testosterone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Transdermal Testosterone Sales by Region (2027-2032) & (W Units) Table 46. Global Transdermal Testosterone Sales Market Share in Volume by Region (2027-2032) Table 47. Global Transdermal Testosterone Sales by Region (2027-2032) & (US$ Million) Table 48. Global Transdermal Testosterone Sales Market Share in Value by Region (2027-2032) Table 49. Global Transdermal Testosterone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Transdermal Testosterone Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Transdermal Testosterone Sales by Application (2021-2026) & (W Units) Table 52. Global Transdermal Testosterone Sales Market Share in Volume by Application (2021-2026) Table 53. Global Transdermal Testosterone Sales by Application (2021-2026) & (US$ Million) Table 54. Global Transdermal Testosterone Sales Market Share in Value by Application (2021-2026) Table 55. Global Transdermal Testosterone Price by Application (2021-2026) & (US$/Unit) Table 56. Global Transdermal Testosterone Sales by Application (2027-2032) & (W Units) Table 57. Global Transdermal Testosterone Sales Market Share in Volume by Application (2027-2032) Table 58. Global Transdermal Testosterone Sales by Application (2027-2032) & (US$ Million) Table 59. Global Transdermal Testosterone Sales Market Share in Value by Application (2027-2032) Table 60. Global Transdermal Testosterone Price by Application (2027-2032) & (US$/Unit) Table 61. North America Transdermal Testosterone Sales by Application (2021-2026) & (W Units) Table 62. North America Transdermal Testosterone Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Transdermal Testosterone Sales by Application (2021-2026) & (W Units) Table 64. Europe Transdermal Testosterone Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Transdermal Testosterone Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Transdermal Testosterone Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Transdermal Testosterone Sales by Application (2021-2026) & (W Units) Table 68. Latin America Transdermal Testosterone Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Transdermal Testosterone Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Transdermal Testosterone Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Transdermal Testosterone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Teva Transdermal Testosterone Product Portfolio Table 75. Teva Recent Development Table 76. AbbVie Company Information Table 77. AbbVie Business Overview Table 78. AbbVie Transdermal Testosterone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. AbbVie Transdermal Testosterone Product Portfolio Table 80. AbbVie Recent Development Table 81. Upsher-Smith Laboratories Company Information Table 82. Upsher-Smith Laboratories Business Overview Table 83. Upsher-Smith Laboratories Transdermal Testosterone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Upsher-Smith Laboratories Transdermal Testosterone Product Portfolio Table 85. Upsher-Smith Laboratories Recent Development Table 86. Perrigo Company Information Table 87. Perrigo Business Overview Table 88. Perrigo Transdermal Testosterone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Perrigo Transdermal Testosterone Product Portfolio Table 90. Perrigo Recent Development Table 91. Lupin Company Information Table 92. Lupin Business Overview Table 93. Lupin Transdermal Testosterone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Lupin Transdermal Testosterone Product Portfolio Table 95. Lupin Recent Development Table 96. Endo Pharmaceuticals Company Information Table 97. Endo Pharmaceuticals Business Overview Table 98. Endo Pharmaceuticals Transdermal Testosterone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Endo Pharmaceuticals Transdermal Testosterone Product Portfolio Table 100. Endo Pharmaceuticals Recent Development Table 101. Dr. Reddy's Laboratories Company Information Table 102. Dr. Reddy's Laboratories Business Overview Table 103. Dr. Reddy's Laboratories Transdermal Testosterone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Dr. Reddy's Laboratories Transdermal Testosterone Product Portfolio Table 105. Dr. Reddy's Laboratories Recent Development Table 106. Cipla Inc. Company Information Table 107. Cipla Inc. Business Overview Table 108. Cipla Inc. Transdermal Testosterone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Cipla Inc. Transdermal Testosterone Product Portfolio Table 110. Cipla Inc. Recent Development Table 111. Allergan Company Information Table 112. Allergan Business Overview Table 113. Allergan Transdermal Testosterone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Allergan Transdermal Testosterone Product Portfolio Table 115. Allergan Recent Development Table 116. Acerus Pharmaceuticals Company Information Table 117. Acerus Pharmaceuticals Business Overview Table 118. Acerus Pharmaceuticals Transdermal Testosterone Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Acerus Pharmaceuticals Transdermal Testosterone Product Portfolio Table 120. Acerus Pharmaceuticals Recent Development Table 121. North America Transdermal Testosterone Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 122. North America Transdermal Testosterone Sales by Country (2021-2026) & (W Units) Table 123. North America Transdermal Testosterone Sales Market Share by Country (2021-2026) Table 124. North America Transdermal Testosterone Sales Forecast by Country (2027-2032) & (W Units) Table 125. North America Transdermal Testosterone Sales Market Share Forecast by Country (2027-2032) Table 126. North America Transdermal Testosterone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Transdermal Testosterone Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Transdermal Testosterone Market Share by Country (2021-2026) Table 129. North America Transdermal Testosterone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Transdermal Testosterone Market Share Forecast by Country (2027-2032) Table 131. Europe Transdermal Testosterone Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 132. Europe Transdermal Testosterone Sales by Country (2021-2026) & (W Units) Table 133. Europe Transdermal Testosterone Sales Market Share by Country (2021-2026) Table 134. Europe Transdermal Testosterone Sales Forecast by Country (2027-2032) & (W Units) Table 135. Europe Transdermal Testosterone Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Transdermal Testosterone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Transdermal Testosterone Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Transdermal Testosterone Market Share by Country (2021-2026) Table 139. Europe Transdermal Testosterone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Transdermal Testosterone Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Transdermal Testosterone Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Transdermal Testosterone Sales by Country (2021-2026) & (W Units) Table 143. Asia-Pacific Transdermal Testosterone Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Transdermal Testosterone Sales Forecast by Country (2027-2032) & (W Units) Table 145. Asia-Pacific Transdermal Testosterone Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Transdermal Testosterone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Transdermal Testosterone Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Transdermal Testosterone Market Share by Country (2021-2026) Table 149. Asia-Pacific Transdermal Testosterone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Transdermal Testosterone Market Share Forecast by Country (2027-2032) Table 151. Latin America Transdermal Testosterone Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 152. Latin America Transdermal Testosterone Sales by Country (2021-2026) & (W Units) Table 153. Latin America Transdermal Testosterone Sales Market Share by Country (2021-2026) Table 154. Latin America Transdermal Testosterone Sales Forecast by Country (2027-2032) & (W Units) Table 155. Latin America Transdermal Testosterone Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Transdermal Testosterone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Transdermal Testosterone Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Transdermal Testosterone Market Share by Country (2021-2026) Table 159. Latin America Transdermal Testosterone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Transdermal Testosterone Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Transdermal Testosterone Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Transdermal Testosterone Sales by Country (2021-2026) & (W Units) Table 163. Middle East and Africa Transdermal Testosterone Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Transdermal Testosterone Sales Forecast by Country (2027-2032) & (W Units) Table 165. Middle East and Africa Transdermal Testosterone Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Transdermal Testosterone Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Transdermal Testosterone Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Transdermal Testosterone Market Share by Country (2021-2026) Table 169. Middle East and Africa Transdermal Testosterone Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Transdermal Testosterone Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Transdermal Testosterone Distributors List Table 174. Transdermal Testosterone Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Transdermal Testosterone Image Figure 2. Global Transdermal Testosterone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Testosterone Market Size (2021-2032) & (US$ Million) Figure 4. Global Transdermal Testosterone Sales (2021-2032) & (W Units) Figure 5. Gel Image Figure 6. Global Gel Sales YoY Growth (2021-2032) & (W Units) Figure 7. Patch Image Figure 8. Global Patch Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Transdermal Testosterone Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Transdermal Testosterone Market Share by Type 2025 VS 2032 Figure 11. North America Transdermal Testosterone Sales Market Share in Volume by Type in 2025 Figure 12. North America Transdermal Testosterone Sales Market Share in Value by Type in 2025 Figure 13. Europe Transdermal Testosterone Sales Market Share in Volume by Type in 2025 Figure 14. Europe Transdermal Testosterone Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Transdermal Testosterone Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Transdermal Testosterone Sales Market Share in Value by Type in 2025 Figure 17. Latin America Transdermal Testosterone Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Transdermal Testosterone Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Transdermal Testosterone Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Transdermal Testosterone Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Transdermal Testosterone Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Late-Onset Hypogonadism Image Figure 24. Global Late-Onset Hypogonadism Sales YoY Growth (2021-2032) & (W Units) Figure 25. Hypogonadotropic Hypogonadism Image Figure 26. Global Hypogonadotropic Hypogonadism Sales YoY Growth (2021-2032) & (W Units) Figure 27. Primary Hypogonadism Image Figure 28. Global Primary Hypogonadism Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Transdermal Testosterone Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Transdermal Testosterone Market Share by Application 2025 VS 2032 Figure 31. North America Transdermal Testosterone Sales Market Share in Volume by Application in 2025 Figure 32. North America Transdermal Testosterone Sales Market Share in Value by Application in 2025 Figure 33. Europe Transdermal Testosterone Sales Market Share in Volume by Application in 2025 Figure 34. Europe Transdermal Testosterone Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Transdermal Testosterone Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Transdermal Testosterone Sales Market Share in Value by Application in 2025 Figure 37. Latin America Transdermal Testosterone Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Transdermal Testosterone Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Transdermal Testosterone Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Transdermal Testosterone Sales Market Share in Value by Application in 2025 Figure 41. North America Transdermal Testosterone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Transdermal Testosterone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Transdermal Testosterone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Transdermal Testosterone Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Transdermal Testosterone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Transdermal Testosterone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Transdermal Testosterone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Transdermal Testosterone Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Transdermal Testosterone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Transdermal Testosterone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Transdermal Testosterone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Transdermal Testosterone Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Transdermal Testosterone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Transdermal Testosterone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Transdermal Testosterone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Transdermal Testosterone Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Transdermal Testosterone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Transdermal Testosterone Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Transdermal Testosterone Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Transdermal Testosterone Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Transdermal Testosterone Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Transdermal Testosterone Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Gel
  • Patch
Applications
  • Late-Onset Hypogonadism
  • Hypogonadotropic Hypogonadism
  • Primary Hypogonadism
Companies covered
  • Teva
  • AbbVie
  • Upsher-Smith Laboratories
  • Perrigo
  • Lupin
  • Endo Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Cipla Inc.
  • Allergan
  • Acerus Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Transdermal Testosterone Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Transdermal Testosterone Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Transdermal Testosterone Market by Type
  6. 1.3.1 Gel
  7. 1.3.2 Patch
  8. 1.4 Global Transdermal Testosterone Market Size by Type
  9. 1.4.1 Global Transdermal Testosterone Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Transdermal Testosterone Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Transdermal Testosterone Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Transdermal Testosterone Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Transdermal Testosterone Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Transdermal Testosterone Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Transdermal Testosterone Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Transdermal Testosterone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Transdermal Testosterone Industry Trends
  2. 2.2 Transdermal Testosterone Industry Drivers
  3. 2.3 Transdermal Testosterone Industry Opportunities and Challenges
  4. 2.4 Transdermal Testosterone Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Transdermal Testosterone Revenue (2021-2026)
  2. 3.2 Global Top Players by Transdermal Testosterone Sales (2021-2026)
  3. 3.3 Global Top Players by Transdermal Testosterone Price (2021-2026)
  4. 3.4 Global Transdermal Testosterone Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Transdermal Testosterone Major Company Production Sites & Headquarters
  6. 3.6 Global Transdermal Testosterone Company, Product Type & Application
  7. 3.7 Global Transdermal Testosterone Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Transdermal Testosterone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Transdermal Testosterone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Transdermal Testosterone Tier 1, Tier 2, and Tier 3
4 Transdermal Testosterone Regional Status and Outlook
  1. 4.1 Global Transdermal Testosterone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Transdermal Testosterone Historic Market Size by Region
  3. 4.2.1 Global Transdermal Testosterone Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Transdermal Testosterone Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Transdermal Testosterone Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Transdermal Testosterone Forecasted Market Size by Region
  7. 4.3.1 Global Transdermal Testosterone Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Transdermal Testosterone Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Transdermal Testosterone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Transdermal Testosterone by Application
  1. 5.1 Transdermal Testosterone Market by Application
  2. 5.1.1 Late-Onset Hypogonadism
  3. 5.1.2 Hypogonadotropic Hypogonadism
  4. 5.1.3 Primary Hypogonadism
  5. 5.2 Global Transdermal Testosterone Market Size by Application
  6. 5.2.1 Global Transdermal Testosterone Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Transdermal Testosterone Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Transdermal Testosterone Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Transdermal Testosterone Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Transdermal Testosterone Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Transdermal Testosterone Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Transdermal Testosterone Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Transdermal Testosterone Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Transdermal Testosterone Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 AbbVie
  8. 6.2.1 AbbVie Company Information
  9. 6.2.2 AbbVie Business Overview
  10. 6.2.3 AbbVie Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AbbVie Transdermal Testosterone Product Portfolio
  12. 6.2.5 AbbVie Recent Developments
  13. 6.3 Upsher-Smith Laboratories
  14. 6.3.1 Upsher-Smith Laboratories Company Information
  15. 6.3.2 Upsher-Smith Laboratories Business Overview
  16. 6.3.3 Upsher-Smith Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Upsher-Smith Laboratories Transdermal Testosterone Product Portfolio
  18. 6.3.5 Upsher-Smith Laboratories Recent Developments
  19. 6.4 Perrigo
  20. 6.4.1 Perrigo Company Information
  21. 6.4.2 Perrigo Business Overview
  22. 6.4.3 Perrigo Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Perrigo Transdermal Testosterone Product Portfolio
  24. 6.4.5 Perrigo Recent Developments
  25. 6.5 Lupin
  26. 6.5.1 Lupin Company Information
  27. 6.5.2 Lupin Business Overview
  28. 6.5.3 Lupin Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lupin Transdermal Testosterone Product Portfolio
  30. 6.5.5 Lupin Recent Developments
  31. 6.6 Endo Pharmaceuticals
  32. 6.6.1 Endo Pharmaceuticals Company Information
  33. 6.6.2 Endo Pharmaceuticals Business Overview
  34. 6.6.3 Endo Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Endo Pharmaceuticals Transdermal Testosterone Product Portfolio
  36. 6.6.5 Endo Pharmaceuticals Recent Developments
  37. 6.7 Dr. Reddy's Laboratories
  38. 6.7.1 Dr. Reddy's Laboratories Company Information
  39. 6.7.2 Dr. Reddy's Laboratories Business Overview
  40. 6.7.3 Dr. Reddy's Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Dr. Reddy's Laboratories Transdermal Testosterone Product Portfolio
  42. 6.7.5 Dr. Reddy's Laboratories Recent Developments
  43. 6.8 Cipla Inc.
  44. 6.8.1 Cipla Inc. Company Information
  45. 6.8.2 Cipla Inc. Business Overview
  46. 6.8.3 Cipla Inc. Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Cipla Inc. Transdermal Testosterone Product Portfolio
  48. 6.8.5 Cipla Inc. Recent Developments
  49. 6.9 Allergan
  50. 6.9.1 Allergan Company Information
  51. 6.9.2 Allergan Business Overview
  52. 6.9.3 Allergan Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Allergan Transdermal Testosterone Product Portfolio
  54. 6.9.5 Allergan Recent Developments
  55. 6.10 Acerus Pharmaceuticals
  56. 6.10.1 Acerus Pharmaceuticals Company Information
  57. 6.10.2 Acerus Pharmaceuticals Business Overview
  58. 6.10.3 Acerus Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Acerus Pharmaceuticals Transdermal Testosterone Product Portfolio
  60. 6.10.5 Acerus Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Transdermal Testosterone Sales by Country
  2. 7.1.1 North America Transdermal Testosterone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Transdermal Testosterone Sales by Country (2021-2026)
  4. 7.1.3 North America Transdermal Testosterone Sales Forecast by Country (2027-2032)
  5. 7.2 North America Transdermal Testosterone Market Size by Country
  6. 7.2.1 North America Transdermal Testosterone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Transdermal Testosterone Market Size by Country (2021-2026)
  8. 7.2.3 North America Transdermal Testosterone Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Transdermal Testosterone Sales by Country
  2. 8.1.1 Europe Transdermal Testosterone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Transdermal Testosterone Sales by Country (2021-2026)
  4. 8.1.3 Europe Transdermal Testosterone Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Transdermal Testosterone Market Size by Country
  6. 8.2.1 Europe Transdermal Testosterone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Transdermal Testosterone Market Size by Country (2021-2026)
  8. 8.2.3 Europe Transdermal Testosterone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Transdermal Testosterone Sales by Country
  2. 9.1.1 Asia-Pacific Transdermal Testosterone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Transdermal Testosterone Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Transdermal Testosterone Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Transdermal Testosterone Market Size by Country
  6. 9.2.1 Asia-Pacific Transdermal Testosterone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Transdermal Testosterone Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Transdermal Testosterone Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Transdermal Testosterone Sales by Country
  2. 10.1.1 South America Transdermal Testosterone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Transdermal Testosterone Sales by Country (2021-2026)
  4. 10.1.3 South America Transdermal Testosterone Sales Forecast by Country (2027-2032)
  5. 10.2 South America Transdermal Testosterone Market Size by Country
  6. 10.2.1 South America Transdermal Testosterone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Transdermal Testosterone Market Size by Country (2021-2026)
  8. 10.2.3 South America Transdermal Testosterone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Transdermal Testosterone Sales by Country
  2. 11.1.1 Middle East and Africa Transdermal Testosterone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Transdermal Testosterone Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Transdermal Testosterone Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Transdermal Testosterone Market Size by Country
  6. 11.2.1 Middle East and Africa Transdermal Testosterone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Transdermal Testosterone Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Transdermal Testosterone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Transdermal Testosterone Value Chain Analysis
  2. 12.1.1 Transdermal Testosterone Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Transdermal Testosterone Production Mode & Process
  7. 12.2 Transdermal Testosterone Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Transdermal Testosterone Distributors
  10. 12.2.3 Transdermal Testosterone Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst